Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianlin Xu

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
Biotechnology Progress|April 27, 2023
An adaptive modeling approach using spiking-augmentation method to improve chemometric model performance in bioprocess monitoringYuxiang Zhao, Yawen Tang, Dhanuka Wasalathanthri, et al.
Journal of Cancer Research and Clinical Oncology|October 21, 2018
Analysis of unexpected small cell lung cancer following surgery as the primary treatmentHaitang Yang, Jianlin Xu, Feng Yao, et al.
Thoracic Cancer|December 19, 2018
Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non-predominant lung adenocarcinomaShuhui Cao, Jiajun Teng, Jianlin Xu, et al.
Cancer Biology & Therapy|March 27, 2024
Prognostic value of pretreatment procalcitonin and neutrophil-lymphocyte ratio in extensive-stage small-cell lung cancerDongfang Chen, Jianlin Xu, Yizhuo Zhao, et al.
The European Journal of Neuroscience|July 8, 2025
Brain-Computer Interfaces in Spinal Cord Injury: A Promising Therapeutic StrategyShizhe Li, Shutao Gao, Yukun Hu, et al.
Cancer Science|December 31, 2024
Osimertinib for EGFR-Mutant NSCLC Patients With Acquired T790M and EGFR Amplification After First-Generation EGFR-TKI ResistanceYidan Zhang, Yingqi Xu, Jianlin Xu, et al.
Clinical Lung Cancer|September 9, 2022
Pathological Stage N1 Limited-Stage Small-Cell Lung Cancer Patients Can Benefit From Surgical ResectionLian Yu, Jianlin Xu, Rong Qiao, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 25, 2017
A mechanistic kinetic description of lactate dehydrogenase elucidating cancer diagnosis and inhibitor evaluationPeifeng Tang, Jianlin Xu, Christopher L Oliveira, et al.
Mabs|April 5, 2022
Upstream cell culture process characterization and in-process control strategy development at pandemic speedJianlin Xu, Jianfa Ou, Kyle P McHugh, et al.
Marine Drugs|March 24, 2022
Rapid Mining of Novel <i>α</i>-Glucosidase and Lipase Inhibitors from <i>Streptomyces</i> sp. HO1518 Using UPLC-QTOF-MS/MSJianlin Xu, Zhifeng Liu, Zhanguang Feng, et al.
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
Biotechnology Progress|April 27, 2023
An adaptive modeling approach using spiking-augmentation method to improve chemometric model performance in bioprocess monitoringYuxiang Zhao, Yawen Tang, Dhanuka Wasalathanthri, et al.
Journal of Cancer Research and Clinical Oncology|October 21, 2018
Analysis of unexpected small cell lung cancer following surgery as the primary treatmentHaitang Yang, Jianlin Xu, Feng Yao, et al.
Thoracic Cancer|December 19, 2018
Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non-predominant lung adenocarcinomaShuhui Cao, Jiajun Teng, Jianlin Xu, et al.
Cancer Biology & Therapy|March 27, 2024
Prognostic value of pretreatment procalcitonin and neutrophil-lymphocyte ratio in extensive-stage small-cell lung cancerDongfang Chen, Jianlin Xu, Yizhuo Zhao, et al.
The European Journal of Neuroscience|July 8, 2025
Brain-Computer Interfaces in Spinal Cord Injury: A Promising Therapeutic StrategyShizhe Li, Shutao Gao, Yukun Hu, et al.
Cancer Science|December 31, 2024
Osimertinib for EGFR-Mutant NSCLC Patients With Acquired T790M and EGFR Amplification After First-Generation EGFR-TKI ResistanceYidan Zhang, Yingqi Xu, Jianlin Xu, et al.
Clinical Lung Cancer|September 9, 2022
Pathological Stage N1 Limited-Stage Small-Cell Lung Cancer Patients Can Benefit From Surgical ResectionLian Yu, Jianlin Xu, Rong Qiao, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 25, 2017
A mechanistic kinetic description of lactate dehydrogenase elucidating cancer diagnosis and inhibitor evaluationPeifeng Tang, Jianlin Xu, Christopher L Oliveira, et al.
Mabs|April 5, 2022
Upstream cell culture process characterization and in-process control strategy development at pandemic speedJianlin Xu, Jianfa Ou, Kyle P McHugh, et al.
Marine Drugs|March 24, 2022
Rapid Mining of Novel <i>α</i>-Glucosidase and Lipase Inhibitors from <i>Streptomyces</i> sp. HO1518 Using UPLC-QTOF-MS/MSJianlin Xu, Zhifeng Liu, Zhanguang Feng, et al.
Pageof 14